Pharsight

BIOGEN MA INC PATENTS FACING OPPOSITIONS

Top patents of BIOGEN MA INC facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3575792B1 30 Nov, 2022 Method Of Assessing Risk Of Pml May, 2032 2
EP2676967B1 14 Aug, 2019 Methods Of Treating Inflammatory And Autoimmune Diseases With Natalizumab Feb, 2027 1
EP1991267B1 20 Dec, 2017 Methods Of Treating Inflammatory And Autoimmune Diseases With Natalizumab Mar, 2027 1